Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Arcturus Therapeutics Hldgs (ARCT)

124 + Investors. Track Smart Money conviction in ARCT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +3
Streak
1Q ▲
Buyers last Q
54%

Smart Money Signals — ARCT

Based on 125 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added ARCT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 71% of 3.0Y peak

71% of all-time peak
125 funds currently hold this stock — 71% of the 3.0-year high of 176 funds (reached 2024 Q1). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 13% fewer funds vs a year ago

fund count last 6Q
19 fewer hedge funds hold ARCT compared to a year ago (-13% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟡

Slight buying edge — 54% buying

73 buying61 selling
Last quarter: 73 funds bought or added vs 61 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~27 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 27 → 21 → 26 → 27. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

61% of holders stayed for 2+ years

■ 61% conviction (2yr+) ■ 20% medium ■ 19% new
76 out of 125 hedge funds have held ARCT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +27% but shares only +3% — price-driven

Value
+27%
Shares
+3%
Last quarter: the total dollar value of institutional holdings rose +27%, but actual share count only changed +3%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

22 → 27 → 21 → 26 → 27 new funds/Q
New funds entering each quarter: 27 → 21 → 26 → 27. A growing number of institutions are discovering ARCT each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 67% veterans vs 20% newcomers

■ 67% veterans ■ 13% 1-2yr ■ 20% new
Entry-cohort mix of 130 holders: 87 (67%) are 2+ year veterans, 17 entered 1–2 years ago, and 26 (20%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 29% AUM from major funds

29% from top-100 AUM funds
36 of 124 holders rank in the top 100 by AUM, accounting for 29% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
2.0
out of 10
Low Exit Risk
Exit risk score 2.0/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ARCT

In 2026 Q1, 73 hedge funds were net buyers of ARCT (27 opened a new position, 46 added to an existing one), while 61 reduced or exited (37 trimmed, 24 sold completely) — a 54% buyer ratio, indicating a slight buying edge. 29% of total institutional value in ARCT is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +3 funds (more new holders than closures). Total institutional holders: 125.

Hedge Fund Ownership: ARCT

How many hedge funds hold ARCT — quarterly history vs. share price
Quarterly hedge fund ownership of ARCT vs. share price

Market Analysis: ARCT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ARCT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Arcturus Therapeutics Hldgs (ARCT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ARCT has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 78d ago
ARCT
-7.5%
XLV
+4.3%

ARCT outperformed XLV by -11.8% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 33d ago
ARCT
-4.4%
XLV
+5.4%

Since the filing became public, ARCT outperformed XLV by -9.8% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

17 top-rated funds 0 high-conviction
Consensus
5.5
/ 10
breadth
×
Elite
0.3
/ 10
conviction
Hedge Fund Positioning: ARCT
124 + Investors

Track Smart Money conviction in ARCT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 124 122 1.64%
13F Shares 25M 24M 3.42%
Total Value $189M $148M 27.45%
New Positions 26 26 -
Increased Positions 45 40 +5
Closed Positions 24 45 -21
Reduced Positions 37 39 -2
Total Calls 4 6 -33.33%
Total Puts 2 6 -66.67%
PUT/CALL Ratio 0.5 1.0 Bullish

Statistics: ARCT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

124 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ARCT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ARCT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 nVerses Capital, LLC 0.27% 38,236 $295K
2 Amova Asset Management Americas, Inc. 0.25% 2,288,935 $17.6M
3 Green Alpha Advisors, LLC 0.21% 28,138 $217K
4 Empire Life Investments Inc. 0.18% 383,493 $3.0M
5 ARK Investment Management LLC 0.17% 2,769,518 $21.4M
6 Heartland Advisors Inc 0.10% 256,000 $2.0M
7 TritonPoint Partners, LLC 0.08% 28,072 $217K
8 Hennion & Walsh Asset Management, Inc. 0.07% 279,679 $2.2M
9 IQ EQ FUND MANAGEMENT (IRELAND) Ltd 0.07% 114,255 $882K
10 Castleview Partners, LLC 0.07% 16,857 $130K
11 Odyssean, LLC 0.06% 22,956 $177K
12 Federated Hermes, INC. 0.04% 3,303,640 $25.5M
13 Axq Capital, LP 0.02% 22,982 $177K
14 Sumitomo Mitsui Trust Group, Inc. 0.01% 2,288,935 $17.7M
15 Formidable Asset Management, LLC 0.01% 10,600 $65K
16 Inscription Capital, LLC 0.01% 11,774 $91K
17 AlphaQuest LLC 0.01% 23,727 $145K
18 Susquehanna Portfolio Strategies, LLC 0.01% 64,396 $497K
19 Jump Financial, LLC 0.01% 68,293 $527K
20 ADAR1 Capital Management, LLC 0.01% 15,000 $116K
21 Two Sigma Investments, LP 0.01% 1,081,784 $8.4M
22 Jacobs Levy Equity Management, Inc 0.01% 198,728 $1.5M
23 Two Sigma Advisers, LP 0.01% 511,043 $3.1M
24 Bridgeway Capital Management, LLC 0.01% 36,500 $282K
25 Engineers Gate Manager LP 0.00% 45,833 $354K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Arcturus Therapeutics Hldgs (ARCT)

What does the Smart Money Trend signal show for ARCT?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added ARCT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ARCT?

Slight buying edge — 54% buying: Last quarter: 73 funds bought or added vs 61 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ARCT holders?

Strong quality — 29% AUM from major funds: 36 of 124 holders rank in the top 100 by AUM, accounting for 29% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ARCT?

61% of holders stayed for 2+ years: 76 out of 125 hedge funds have held ARCT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Arcturus Therapeutics Hldgs (ARCT) following the 2026 Q1 hedge fund 13F filings?

As of today, ARCT has moved -4.4% since the 2026 Q1 13F filing date (May 15, 2026), compared to +5.4% for the XLV sector ETF — an outperformance of -9.8%. Since the quarter end (March 31, 2026), ARCT has gained -7.5% vs +4.3% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →